Image

Global Neutropenia Market – Industry Trends and Forecast to 2029

  • Pharmaceutical
  • Upcoming Report
  • Sep 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Neutropenia Market, By Type (Congenital Neutropenia, Idiopathic Neutropenia, Cyclic Neutropenia, Autoimmune Neutropenia, Others), Treatment (Antibiotic Therapy, Colony-Stimulating Factor Therapy, Granulocyte Transfusion, Splenectomy Procedure, Others), Route of Administration (Oral, Injectable), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029.

Neutropenia Market

Neutropenia Market Analysis and Size

The neutropenia market is expected to witness significant growth during the forecast period. The neutropenia market is mainly boosted by high prevalence of cancer where chemotherapy is the primary treatment which causes chemotherapy, induced neutropenia and promising pipeline drugs. Multiple treatment landscape and effective diagnosis are considered positive indicators for the demand for the growth of neutropenia market. COVID-19 also had a major impact on the market growth.

Data Bridge Market Research analyses a growth rate in the global neutropenia market in the forecast period 2022-2029. The expected CAGR of global neutropenia market is tend to be around 5.50% in the mentioned forecast period. The market was valued at USD 13.2 billion in 2021, and it would grow upto USD 20.26 billion by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Definition

Neutropenia is haematological disorder which are characterized by abnormally low concentration of neutrophils that leads to a compromised immune system. These are a type of white blood cells which is an essential component of blood that helps in the fighting against infections. Low count of neutrophils can lead to spectrum of distressing infectious diseases. It is of great importance to the healthcare sector and thus is expected to rise high in the forecast period

Neutropenia Market Scope and Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Type (Congenital Neutropenia, Idiopathic Neutropenia, Cyclic Neutropenia, Autoimmune Neutropenia, Others), Treatment (Antibiotic Therapy, Colony-Stimulating Factor Therapy, Granulocyte Transfusion, Splenectomy Procedure, Others), Route of Administration (Oral, Injectable), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd.(Israel), Sanofi (France), Pfizer Inc. (U.S.), GSK plc (U.K.), Novartis AG (Switzerland), Bayer AG (Germany), Merck & Co., Inc. (U.S.), AstraZeneca (U.K.), Cipla Inc. (U.S.), Abbott (U.S.), Bausch Health Companies Inc. (Canada), Lupin (India), Hikma Pharmaceuticals PLC (U.K.), Amneal Pharmaceuticals LLC. (U.S.), Seagen, Inc (U.S.), ONO Pharmaceutical Co., Ltd. (Japan), Coherus BioSciences (U.S.)

Market Opportunities

  • Increase in Cancer Cases
  • Rising Healthcare Awareness

Global Neutropenia Market Dynamics

Drivers

  • Increasing Investments by Market Players

Several growth strategies such as novel product launches aid in leading market players gain a competitive edge over the other players, in the upcoming years. Collaboration between major market players and smaller players can help increase their revenue shares. The smaller market leaders will acquire investments from private investors, which in turn could help them in their long-term growth.

Oral drugs is expected to boost the market growth. The segment is expected to accelerate the global market as most products are available in capsule and tablet form and it is a very feasible route of administration.

Opportunities

  • Increase in Cancer Cases

The rising prevalence of cancer is boosting the growth of the market. The incidence of patients with cancer in India among males was 679,421 and that for females was 712,758 for the year 2020. Thus, it boosts the market growth.

  • Rising Healthcare Awareness

Health awareness amongst the population are rising which results in the prediction of drugs to boost the market growth. The innovative launches in medications for the treatment of ovarian cancer are expected to prompt the market simultaneously. Different researchers are investing in launching drugs that benefit the market. For instance, several novel products such as Taiho Pharmaceutical’s drugs, ZOSYN 2.5, ZOSYN 4.5 for I.V. infusion bag, and ZOSYN 4.5 are in the pipeline and these products are expected to change the treatment growth. This creates more opportunity in the market.

Restraints/Challenges

  • Lack of Skilled Professionals

Lack of trained professionals who are unaware of the knowledge of the treatment methods for this disease could curb the growth of the global neutropenia market over a forecast period.

  • High Cost

The huge expenditure of the treatment methods surely hamper the market growth. Many times, due to lack of appropriate payment plans and special considerations by the organizations, the patients fail to adapt these high-end treatment options which in return hampers their health. Thus, this is an important restrain that needs to be taken care of.

This global neutropenia market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global neutropenia market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Neutropenia Market Scope

The global neutropenia market is segmented on the basis of type, treatment, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Congenital Neutropenia
  • Idiopathic Neutropenia
  • Cyclic Neutropenia
  • Autoimmune Neutropenia
  • Others

Treatment

  • Antibiotic Therapy
  • Colony-Stimulating Factor Therapy
  • Granulocyte Transfusion
  • Splenectomy Procedure
  • Others

Route of Administration

  • Oral
  • Injectable

End-Users

  • Hospitals
  • Homecare
  • Speciality Centres
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Neutropenia Market Regional Analysis/Insights

The global neutropenia market is analysed and market size insights and trends are provided by type, treatment, route of administration, distribution channel and end-user as referenced above.

The major countries covered in the global neutropenia market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is expected to have the highest market growth due to the high demand for disease-specific treatment, rise in adoption of newer technologies, presence of refined healthcare expenditure, increased patient awareness level, and high prevalence of bleeding disorders.

Asia-Pacific dominates the market due to the number of generic manufacturers in this region and increasing disposable income.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Neutropenia Market Share Analysis

The global neutropenia market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global neutropenia market.

Key players operating in the global neutropenia market include:

  • Mylan N.V. (U.S.)
  • Teva Pharmaceutical Industries Ltd.(Israel)
  • Sanofi (France)
  • Pfizer Inc. (U.S.)
  • GSK plc (U.K.)
  • Novartis AG (Switzerland)
  • Bayer AG (Germany)
  • Merck & Co., Inc. (U.S.)
  • AstraZeneca (U.K.)
  • Cipla Inc. (U.S.)
  • Abbott (U.S.)
  • Bausch Health Companies Inc. (Canada)
  •  Lupin (India)
  • Hikma Pharmaceuticals PLC (U.K.)
  • Amneal Pharmaceuticals LLC. (U.S.)
  • Seagen, Inc (U.S.)
  • ONO Pharmaceutical Co., Ltd. (Japan)
  • Coherus BioSciences (U.S.)

Research Methodology: Global Neutropenia Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions

The global neutropenia market was USD 13.2 billion in 2021.
The global neutropenia market is projected to grow at a CAGR of 5.50% during the forecast period of 2022-2029.